Morgan Stanley B.V. ISSUER CALL - MSBV - 14 Jan 2025-XS2629933966

RNS Number : 2994T

Morgan Stanley B.V.

14 January 2025

 

	Morgan Stanley & Co. International plc 25 Cabot Square Canary Wharf E14 4QA
14 January 2025

ISSUER CALL NOTICE

Dear All,

Morgan Stanley B.V., as issuer of the Notes identified below, hereby notifies the Noteholders that it has exercised its right to Call the Notes in whole, in accordance with Condition 24.6 of the Terms and Conditions of the Notes, with effect as of the Call Date specified below.

 

ISIN:	XS2629933966
Issuer:	Morgan Stanley B.V.
Structure:	Issue of USD 5,495,000 Equity Linked Notes due 2025
Format:	Registered
Aggregate Notional Amount:	USD 5,495,000
Outstanding Notional	USD 5,495,000
Original Issue Date:	14 July 2023
Original Maturity Date:	14 July 2025
Optional Redemption Date (Call):	14 January 2025
Minimum call Notice Number of Days:	5 Business Days
Optional Redemption Amount (Call):	USD 5,495,000

 

The noteholders are entitled to receive the Optional Redemption Amount (Call). Cash will be delivered by Morgan Stanley & Co. International plc to Bank of New York Mellon on such Optional Redemption Date (Call).

This Pricing Supplement must be read in conjunction with the Offering Circular dated 29 June 2018 (the "Offering Circular"). Full information on the Issuer, the Guarantor and the offer of the Notes is only available on the basis of the combination of this Pricing Supplement and the Offering Circular. Copies of the Offering Circular are available from the offices of Morgan Stanley & Co. International plc at 25 Cabot Square, Canary Wharf, London, E14 4QA. The Offering Circular has also been published on the website of Euronext Dublin (www.ise.ie) and the Luxembourg Stock Exchange (www.bourse.lu).

 

Please do not hesitate to contact us for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCFLFVVLDISLIE